Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Equity Ratio (2016 - 2020)

Historic Equity Ratio for Forte Biosciences (FBRX) over the last 5 years, with Q3 2020 value amounting to 0.89.

  • Forte Biosciences' Equity Ratio rose 21941.7% to 0.89 in Q3 2020 from the same period last year, while for Sep 2020 it was 0.89, marking a year-over-year increase of 21941.7%. This contributed to the annual value of 0.62 for FY2019, which is 21040.23% down from last year.
  • Latest data reveals that Forte Biosciences reported Equity Ratio of 0.89 as of Q3 2020, which was up 21941.7% from 0.88 recorded in Q2 2020.
  • Over the past 5 years, Forte Biosciences' Equity Ratio peaked at 0.89 during Q3 2020, and registered a low of 3.88 during Q1 2017.
  • In the last 5 years, Forte Biosciences' Equity Ratio had a median value of 0.53 in 2018 and averaged 0.01.
  • In the last 5 years, Forte Biosciences' Equity Ratio plummeted by 21040.23% in 2019 and then skyrocketed by 21941.7% in 2020.
  • Forte Biosciences' Equity Ratio (Quarter) stood at 3.52 in 2016, then skyrocketed by 121.94% to 0.77 in 2017, then fell by 26.94% to 0.56 in 2018, then plummeted by 210.4% to 0.62 in 2019, then skyrocketed by 243.55% to 0.89 in 2020.
  • Its Equity Ratio stands at 0.89 for Q3 2020, versus 0.88 for Q2 2020 and 0.11 for Q1 2020.